Adiponectin as a Potential Therapeutic Target for Prostate Cancer-Reference-Cited by-同舟云学术

Adiponectin as a Potential Therapeutic Target for Prostate Cancer

Published:2017-11-02 Issue:28 Volume:23 Page:
ISSN:1381-6128
Container-title:Current Pharmaceutical Design
language:en
Short-container-title:CPD

Author:

Karnati Hanuma Kumar¹,Panigrahi Manas Kumar²,Li Yazhou¹,Tweedie David¹,Greig Nigel H.¹

Affiliation:

1. Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, 21224, United States

2. Department of Neurosurgery, Krishna Institute of Medical Sciences (KIMS), Hyderabad- 500003, Telangana, India

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of obesity and sexual behavior on prostate cancer risk is mediated by testosterone levels: a mendelian randomization study and mediation analysis;Prostate International;2024-06

2. Challenges in Pharmacological Intervention in Perilipins (PLINs) to Modulate Lipid Droplet Dynamics in Obesity and Cancer;Cancers;2023-08-07

3. Körperliche Aktivität, Immunsystem und onkologische Erkrankungen;Bewegungsmangel;2023

4. Inhibition of obesity through alterations of C/EBP- α gene expression by gum Arabic in mice with a high-fat feed diet;Carbohydrate Polymer Technologies and Applications;2022-12

5. Adiponectin inhibits the activation of lung fibroblasts and pulmonary fibrosis by regulating the nuclear factor kappa B (NF-κB) pathway;Bioengineered;2022-04-01